R-E-S-P-E-C-T, and the skinny on obesity
Boeing Boeing
Job actions by unions and their members, especially those involving big unions and big companies, pretty much always go according to script. Oh, they are unpredictable in duration and outcome, of course, but the sturm und drang, subtle and sometimes not so attempts to divide workers from their union, news-cycle-timed expressions of outrage, camera-ready picket line energy — all textbook.
But Boeing's flight path (sorry) from a 33,000-strong machinists strike that has shut down production has been anything but dull — and we're only two weeks in. And there's … history.?
So it's not too early to think about the movie version. A dramatic, 90-minute action + pathos with some comedy and heartbreak from Puget Sound to the Halls of Congress. Maybe there's even an Erin Brockovich character to tie it all together. Anyway — Elevator pitch: Norma Rae meets Dumb Money .?
Boeing has been a supporting player in plenty of movies — from Airport to Apollo 13 — but this time it could be above the title. It is considered part of an airliner manufacturing duopoly , along with Airbus, and an American manufacturing icon. It's not a particularly large employer — Ford and Disney are bigger, along with dozens of companies you've never heard of. That almost makes it … scrappy!
But where to begin?! At the beginning, sure. But great storytellers decide where the beginning is. Let's tick off some plot points to see what the best entry point might be:
Oh yes, Boeing is buying back Spirit Aerosystems — but I digress. Also not a bad cinematic technique. Now, back to our story:
And this is where our tale takes another turn:
This tactic is a blatant show of disrespect to you - our members - and the bargaining process. Boeing does not get to decide when or if you vote. Boeing has misled the media by wrongfully stating the Union membership is required to vote on their latest offer.
BUT WAIT: PLOT TWIST
Now, about casting…
Forks and knives — out!
Obesity is a touchy topic. But GLP-1s, which burst onto the scene only in the past year or so, are a game changer. They offer the promise of weight control with maintenance meds instead of maintenance eating, increasing the prospects for compliance versus staying on track with diet and exercise.
So, just as speaking openly about mental health has become less taboo, the revolution in weight-control drugs is making this once-taboo subject less so.
But as with any paradigm shift, there are winners and losers. This could have big public policy implications — Medicare, for one — and the private sector — insurance and health-care companies and yes, even (maybe especially) the food and beverage industries. And lest we forget, GLP-1s were developed for and are primarily prescribed to diabetes patients.
With that in mind, we had some sobering news this week on obesity : It has declined among Americans — slightly — in the past two years, compared to the previous three. But it remains higher than 10 years ago; more than 100 million American adults have obesity, and more than 20 million have severe obesity.
Note: These stats probably do not reflect much of the impact of GLP-1s, whose popularity purely for their weight-loss properties has caused worldwide shortages . So the next report will be even more significant.
Which gives us time to think.
Tease this out: If all anyone needed to stay in a healthy weight range was a pill, and could get it cheaply or free, would that be a good outcome? Should we socially engineer this? It would mean that companies in the empty-calorie business would suffer, and people might be thrown out of work. Social Security might be under even greater strain as life expectancies lengthen.
But we'd be a healthier nation. Is that overreach, or sound public policy?
I will gladly pay you Tuesday for a hamburger today
Last week we reported that holiday shopping was "already in full swing " — IT'S SEPTEMBER, PEOPLE. This week we learned that holiday shoppers are forecast to spend a record $18.5 billion using buy now, pay later services, according to projections by Adobe Analytics. That's 11.4% more than last year.
More insights from Adobe:
And, as Axios reports , spend on the most expensive items is expected to grow by 19%:
Trading up — or opting to buy a more expensive option of a product — is a reversal from the act of trading down, which is what many consumers have been choosing to do in light of high inflation.
Shopping earlier, spending more — even accounting for inflation. Is this your profile for the holiday season?
Living Delaware
1 个月Génial
Retired
1 个月Well said John
Author of The Leadership Letter weekly column; Consulting Expert with OnFrontiers; advisor and mentor on leadership and public service; retired U.S. Army and U.S. Citizenship and Immigration Services Officer.
1 个月I was in Wal-Mart the other day, and they had Christmas decorations for sale. Given that fall and Halloween has been on sale since July 5th, can we not just live in the moment?